Vaccinex (VCNX) Competitors $0.94 -0.05 (-5.05%) As of 07/11/2025 03:53 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock VCNX vs. CLDI, APLM, ORGS, PMCB, SLXN, CVM, OMGA, CELZ, AIM, and INDPShould you be buying Vaccinex stock or one of its competitors? The main competitors of Vaccinex include Calidi Biotherapeutics (CLDI), Apollomics (APLM), Orgenesis (ORGS), Nuvilex (PMCB), Silexion Therapeutics (SLXN), CEL-SCI (CVM), Omega Therapeutics (OMGA), Creative Medical Technology (CELZ), AIM ImmunoTech (AIM), and Indaptus Therapeutics (INDP). These companies are all part of the "pharmaceutical products" industry. Vaccinex vs. Its Competitors Calidi Biotherapeutics Apollomics Orgenesis Nuvilex Silexion Therapeutics CEL-SCI Omega Therapeutics Creative Medical Technology AIM ImmunoTech Indaptus Therapeutics Vaccinex (NASDAQ:VCNX) and Calidi Biotherapeutics (NYSE:CLDI) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, media sentiment, earnings, analyst recommendations, valuation, risk, dividends and institutional ownership. Which has preferable earnings & valuation, VCNX or CLDI? Vaccinex has higher revenue and earnings than Calidi Biotherapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVaccinex$388K6.30-$20.25M-$48.27-0.02Calidi BiotherapeuticsN/AN/A-$29.22MN/AN/A Does the media refer more to VCNX or CLDI? In the previous week, Calidi Biotherapeutics had 5 more articles in the media than Vaccinex. MarketBeat recorded 5 mentions for Calidi Biotherapeutics and 0 mentions for Vaccinex. Calidi Biotherapeutics' average media sentiment score of 0.01 beat Vaccinex's score of 0.00 indicating that Calidi Biotherapeutics is being referred to more favorably in the news media. Company Overall Sentiment Vaccinex Neutral Calidi Biotherapeutics Neutral Which has more volatility & risk, VCNX or CLDI? Vaccinex has a beta of 1.1, suggesting that its share price is 10% more volatile than the S&P 500. Comparatively, Calidi Biotherapeutics has a beta of 0.94, suggesting that its share price is 6% less volatile than the S&P 500. Is VCNX or CLDI more profitable? Company Net Margins Return on Equity Return on Assets VaccinexN/A N/A -383.58% Calidi Biotherapeutics N/A N/A -344.45% Do institutionals and insiders have more ownership in VCNX or CLDI? 50.1% of Vaccinex shares are held by institutional investors. Comparatively, 12.5% of Calidi Biotherapeutics shares are held by institutional investors. 51.5% of Vaccinex shares are held by insiders. Comparatively, 6.7% of Calidi Biotherapeutics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. SummaryVaccinex beats Calidi Biotherapeutics on 5 of the 8 factors compared between the two stocks. Get Vaccinex News Delivered to You Automatically Sign up to receive the latest news and ratings for VCNX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VCNX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VCNX vs. The Competition Export to ExcelMetricVaccinexPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.44M$838.34M$5.56B$9.10BDividend YieldN/A4.84%5.06%4.02%P/E Ratio-0.021.3828.2620.26Price / Sales6.30241.37407.54153.01Price / CashN/A17.6937.1257.67Price / Book-0.366.588.045.49Net Income-$20.25M-$23.83M$3.19B$250.45M7 Day Performance34.38%1.59%3.62%4.79%1 Month Performance14.63%-0.08%5.98%9.59%1 Year Performance-85.70%4.35%29.39%16.41% Vaccinex Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VCNXVaccinex0.8234 of 5 stars$0.94-5.1%N/A-85.7%$2.44M$388K-0.0240Gap DownCLDICalidi Biotherapeutics0.5478 of 5 stars$0.23+2.8%N/A-52.0%$7.31M$50K0.0038News CoverageGap DownAPLMApollomics0.6857 of 5 stars$6.56+0.8%N/A-72.1%$7.18M$1.49M0.0045News CoveragePositive NewsORGSOrgenesis1.745 of 5 stars$1.48-1.7%N/AN/A$7.08M$662K0.00150Gap DownPMCBNuvilex2.7953 of 5 stars$1.09+5.8%N/A-48.1%$7.07MN/A1.474Positive NewsSLXNSilexion TherapeuticsN/A$0.81+1.4%$5.00+517.3%N/A$6.95MN/A0.00N/ANews CoveragePositive NewsCVMCEL-SCI0.1681 of 5 stars$2.29-4.6%N/A-90.7%$6.94MN/A-4.7743News CoverageGap UpOMGAOmega Therapeutics2.0261 of 5 stars$0.13-21.8%$8.50+6,700.0%-93.9%$6.92M$8.10M-0.09120Gap UpCELZCreative Medical Technology0.7196 of 5 stars$2.65flatN/A-19.2%$6.85M$10K-0.705News CoveragePositive NewsAIMAIM ImmunoTech1.1234 of 5 stars$8.65-2.8%$275.00+3,079.2%-75.2%$6.80M$146K-18.4020INDPIndaptus Therapeutics3.3734 of 5 stars$10.53-9.5%$238.00+2,160.2%-81.0%$6.66MN/A-0.256Gap Down Related Companies and Tools Related Companies CLDI Competitors APLM Competitors ORGS Competitors PMCB Competitors SLXN Competitors CVM Competitors OMGA Competitors CELZ Competitors AIM Competitors INDP Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VCNX) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vaccinex, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vaccinex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VCNX Stock Alerts